<!DOCTYPE html>
<html>
<head>
    <title>全文阅读--XML全文阅读--中国知网</title>
    <link rel="icon" href="/kxreader/favicon.ico" />
    <link rel="shortcut Icon" href="/kxreader/favicon.ico" />
    <meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
    <meta name="keywords" content="文献 XML KBASE CNKI 中国知网" />
    <meta name="description" content="XML文献检索" />
    <link href="/kxreader/Content/css/detail?v=NOOK-mvTMnxl11s6oPYV0boPXN3iP4N7Rc-A56nk4KI1" rel="stylesheet"/>

    <script type="text/javascript">
        var APPPATH = '/kxreader';
    </script>
</head>

<body>
    
<script type="text/javascript" src="//login.cnki.net/TopLogin/api/loginapi/get?type=top&amp;localCSS=&amp;returnurl=%2f%2fkns.cnki.net%2fKXReader%2fDetail%3fTIMESTAMP%3d637141673041982500%26DBCODE%3dCJFD%26TABLEName%3dCJFDLAST2019%26FileName%3dXXGK201904006%26RESULT%3d1%26SIGN%3d3VQFCUCDiAngJGdscFuIM02%252bhSo%253d"></script>

<div id="headerBox" class="header">
    <div class="topbar">
        <div class="textalign">
            <a href="/kxreader/Detail?dbcode=CJFD&amp;filename=XXGK201904006&amp;align=md">
                <i class="icon-cen active" title="居中对齐"></i>
            </a>
            <a href="/kxreader/Detail?dbcode=CJFD&amp;filename=XXGK201904006&amp;align=lt">
                <i class="icon-left " title="左对齐"></i>
            </a>
        </div>
        <h6 class="free-tip"><i class="icon"></i>HTML阅读开放试用阶段，欢迎体验！</h6>
    </div>
</div>

    



<div class="btn-link" style="display: none"><a target="_blank" href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=XXGK201904006&amp;v=MDc2ODFUWE1aYkc0SDlqTXE0OUZZb1FLREg4NHZSNFQ2ajU0TzN6cXFCdEdGckNVUjdxZlp1Wm1GeWpnV3J6T1A=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">知网节</a></div>

    <div class="main">

        

    <div class="sidebar-a">
        <!--sidebar start-->
        <div class="sidenav">
            <div class="arrow"><span></span></div>
            <!--sidebar_list start-->
            <dl class="sidenav-list">
                    <dt class="tit">目录结构</dt>
                            <dd class="guide">
                                    <p><a href="#29" data-title="&lt;b&gt;1 资料与方法&lt;/b&gt; "><b>1 资料与方法</b></a><i></i></p>
                                                                    <ul class="contentbox">
                                                <li><a href="#30" data-title="1.1 一般资料">1.1 一般资料</a></li>
                                                <li><a href="#32" data-title="1.2 研究设计">1.2 研究设计</a></li>
                                                <li><a href="#34" data-title="1.3 标本采集及血BNP测定">1.3 标本采集及血BNP测定</a></li>
                                                <li><a href="#36" data-title="1.4 超声心动图">1.4 超声心动图</a></li>
                                                <li><a href="#38" data-title="1.5 短期主要不良终点事件 (SMAE) 的判定">1.5 短期主要不良终点事件 (SMAE) 的判定</a></li>
                                                <li><a href="#40" data-title="1.6 统计学方法">1.6 统计学方法</a></li>
                                    </ul>
                            </dd>
                            <dd class="guide">
                                    <p><a href="#43" data-title="&lt;b&gt;2 结 果&lt;/b&gt; "><b>2 结 果</b></a><i></i></p>
                                                                    <ul class="contentbox">
                                                <li><a href="#44" data-title="2.1 基线资料">2.1 基线资料</a></li>
                                                <li><a href="#47" data-title="2.2 三组患者血浆BNP水平比较">2.2 三组患者血浆BNP水平比较</a></li>
                                                <li><a href="#51" data-title="2.3 CHF患者的临床基线特征与SMAE的相关性">2.3 CHF患者的临床基线特征与SMAE的相关性</a></li>
                                    </ul>
                            </dd>
                            <dd class="guide">
                                    <p><a href="#57" data-title="&lt;b&gt;3 讨 论&lt;/b&gt; "><b>3 讨 论</b></a><i></i></p>
                                                            </dd>
                            <dd class="guide">
                                    <p><a href="#" data-title="文内图表 ">文内图表</a><i></i></p>
                                                                    <ul class="contentbox">
                                                <li><a href="#46" data-title="&lt;b&gt;表&lt;/b&gt;1 &lt;b&gt;三组患者的基线资料比较&lt;/b&gt;"><b>表</b>1 <b>三组患者的基线资料比较</b></a></li>
                                                <li><a href="#49" data-title="表2 三组患者血浆脑钠肽水平比较（&lt;image id=&quot;69&quot; type=&quot;formula&quot; href=&quot;images/XXGK201904006_06900.jpg&quot; display=&quot;inline&quot; placement=&quot;inline&quot;&gt;&lt;alt&gt;&lt;/alt&gt;&lt;/image&gt;&#177;s) ">表2 三组患者血浆脑钠肽水平比较（<image id="69" type="formula" href="images/XXGK201904006_06900.jpg" display="inline" placement="inline"><alt></alt></image>±s) </a></li>
                                                <li><a href="#54" data-title="&lt;b&gt;表&lt;/b&gt;3 HFrEF、HFmEF、HFpEF&lt;b&gt;组&lt;/b&gt;BNP&lt;b&gt;及基线资料与患者短期主要不良终点事件的相关性&lt;/b&gt;"><b>表</b>3 HFrEF、HFmEF、HFpEF<b>组</b>BNP<b>及基线资料与患者短期主要不良终点事件的相关性</b></a></li>
                                                <li><a href="#55" data-title="&lt;b&gt;表&lt;/b&gt;4 HFrEF、HFmEF、HFpEF&lt;b&gt;三组患者再入院率比较&lt;/b&gt;"><b>表</b>4 HFrEF、HFmEF、HFpEF<b>三组患者再入院率比较</b></a></li>
                                                <li><a href="#56" data-title="&lt;b&gt;图&lt;/b&gt;1 &lt;b&gt;血浆&lt;/b&gt;BNP&lt;b&gt;预测终点事件的&lt;/b&gt;ROC&lt;b&gt;曲线&lt;/b&gt;"><b>图</b>1 <b>血浆</b>BNP<b>预测终点事件的</b>ROC<b>曲线</b></a></li>
                                    </ul>
                            </dd>
                                    <dd class="guide">
                                        <h6>
                                            <p><a href="#a_bibliography">参考文献</a> </p>
                                        </h6>
                                    </dd>

            </dl>
        </div>
        <!--sidebar end-->
        &nbsp;
        <!--此处有一空格符 勿删-->
    </div>

                <div class="sidebar-b three-collumn" style="width:0;">
            <div class="refer" style="width: 0;">
                <div class="arrow off" title="参考文献"><span></span></div>
                <div class="js-scrollbox" >
                    
                    <div class="subbox active">
                        <h4>
                            <span class="tit">参考文献</span>
                            <a class="close" href="javascript:void(0)">x</a>
                        </h4>
                        <div class="side-scroller">
                            <ul class="refer-list">
                                <li id="5">


                                    <a id="bibliography_1" title="Bhatia RS, Tu JV, Lee DS, et al.Outcome of heart failure with preserved ejection fraction in a population-based study[J].N Engl J Med, 2006, 355 (3) :260-269." target="_blank"
                                       href="http://scholar.cnki.net/result.aspx?q=Outcome of heart failure with preserved ejection fraction in a population-based study">
                                        <b>[1]</b>
                                        Bhatia RS, Tu JV, Lee DS, et al.Outcome of heart failure with preserved ejection fraction in a population-based study[J].N Engl J Med, 2006, 355 (3) :260-269.
                                    </a>
                                </li>
                                <li id="7">


                                    <a id="bibliography_2" title="Steinberg BA, Zhao X, Heidenreich PA, et al.Trends in patients hospitalized with heart failure and preserved left ventricular ejection fraction:prevalence, therapies, and outcomes[J].Circulation, 2012, 126 (1) :65-75." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=SJRS&amp;filename=SJRS120719010560&amp;v=MTIzNzd4VVNtRGQ5U0g3bjN4RTlmYnZuS3JpZlplWnZGeW50VTcvTktWMFNOaWZaZmJLNkh0Yk5wbzlFWk80SkRCTTh6&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[2]</b>
                                        Steinberg BA, Zhao X, Heidenreich PA, et al.Trends in patients hospitalized with heart failure and preserved left ventricular ejection fraction:prevalence, therapies, and outcomes[J].Circulation, 2012, 126 (1) :65-75.
                                    </a>
                                </li>
                                <li id="9">


                                    <a id="bibliography_3" title="Garc&#237;a EH, Perna ER, Far&#237;as EF, et al.Reduced systolic performance by tissue Doppler in patients with preserved and abnormal ejection fraction:new insights in chronic heart failure[J].Int J Cardiol, 2006, 108 (2) :181-188." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=SJES&amp;filename=SJES13012300501433&amp;v=MjYyMDI4Nm9CTVQ2VDRQUUgvaXJSZEdlcnFRVE1ud1plWnRGaW5sVXJmSUlGc2RhUlE9TmlmT2ZiSzdIdERPckk5Rlllc09DSA==&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[3]</b>
                                        Garc&#237;a EH, Perna ER, Far&#237;as EF, et al.Reduced systolic performance by tissue Doppler in patients with preserved and abnormal ejection fraction:new insights in chronic heart failure[J].Int J Cardiol, 2006, 108 (2) :181-188.
                                    </a>
                                </li>
                                <li id="11">


                                    <a id="bibliography_4" title="Borlaug BA, Lam CS, Roger VL, et al.Contractility and ventricular systolic stiffening in hypertensive heart disease insights into the pathogenesis of heart failure with preserved ejection fraction[J].J Am Coll Cardiol, 2009, 54 (5) :410-418." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=SJES&amp;filename=SJES13012100340142&amp;v=MTg4NjBvQk1UNlQ0UFFIL2lyUmRHZXJxUVRNbndaZVp0RmlubFVyZklJRnNkYVJRPU5pZk9mYks3SHRET3JvOUZaKzhQRFhnNw==&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[4]</b>
                                        Borlaug BA, Lam CS, Roger VL, et al.Contractility and ventricular systolic stiffening in hypertensive heart disease insights into the pathogenesis of heart failure with preserved ejection fraction[J].J Am Coll Cardiol, 2009, 54 (5) :410-418.
                                    </a>
                                </li>
                                <li id="13">


                                    <a id="bibliography_5" title="Kaku K, Takeuchi M, Otani K, et al.Age and gender dependency of left ventricular geometry assessed with real-time three dimensional transthoracic echocardiography[J].J Am Soc Echocardiogr, 2011, 24 (5) :541-547." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=SJES&amp;filename=SJES13012300055873&amp;v=MjcyMzQvaXJSZEdlcnFRVE1ud1plWnRGaW5sVXJmSUlGc2RhUlE9TmlmT2ZiSzdIdERPckk5RlpPNEtCSHM2b0JNVDZUNFBRSA==&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[5]</b>
                                        Kaku K, Takeuchi M, Otani K, et al.Age and gender dependency of left ventricular geometry assessed with real-time three dimensional transthoracic echocardiography[J].J Am Soc Echocardiogr, 2011, 24 (5) :541-547.
                                    </a>
                                </li>
                                <li id="15">


                                    <a id="bibliography_6" title="Kainuma S, Taniguchi K, Toda K, et al.B-type natriuretic peptide response and reverse left ventricular remodeling after surgical correction of functional mitral regurgitation in patients with advanced cardiomyopathy[J].J Cardiol, 2015, 66 (4) :279-285." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=SJES&amp;filename=SJES82854A0DEA2666D20C6BB8741C679B35&amp;v=MjI1NzVscUJOR2Y3V2RON21hQ09OdkZTaVdXcjdKSUZwbWFCdUhZZk9HUWxmQnJMVTA1dEJoeEwyMnc2ND1OaWZPZmJ1NkZ0VEkzbzh4RVpvTkNuby91eFFUbVRrUE9uZg==&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[6]</b>
                                        Kainuma S, Taniguchi K, Toda K, et al.B-type natriuretic peptide response and reverse left ventricular remodeling after surgical correction of functional mitral regurgitation in patients with advanced cardiomyopathy[J].J Cardiol, 2015, 66 (4) :279-285.
                                    </a>
                                </li>
                                <li id="17">


                                    <a id="bibliography_7" title="Magne J, Mahjoub H, Pibarot P, et al.Prognostic importance of exercise brain natriuretic peptide in asymptomatic degenerative mitral regurgitation[J].Eur J Heart Fail, 2012, 14 (11) :1293-1302." target="_blank"
                                       href="http://scholar.cnki.net/result.aspx?q=Prognostic importance of exercise brain natriuretic peptide in asymptomatic degenerative mitral regurgitation">
                                        <b>[7]</b>
                                        Magne J, Mahjoub H, Pibarot P, et al.Prognostic importance of exercise brain natriuretic peptide in asymptomatic degenerative mitral regurgitation[J].Eur J Heart Fail, 2012, 14 (11) :1293-1302.
                                    </a>
                                </li>
                                <li id="19">


                                    <a id="bibliography_8" title="Kang SH, Park JJ, Choi DJ, et al.Prognostic value of NTproBNP in heart failure with preserved versus reduced EF[J].Heart, 2015, 101 (23) :1881-1888." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=SJRS&amp;filename=SJRS15112000001402&amp;v=MjAyNjhmYks5SDlET3I0OUZaT3NPQ0h3N29CTVQ2VDRQUUgvaXJSZEdlcnFRVE1ud1plWnRGaW5sVXJmSUlGc2RhUlE9TmlmWg==&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[8]</b>
                                        Kang SH, Park JJ, Choi DJ, et al.Prognostic value of NTproBNP in heart failure with preserved versus reduced EF[J].Heart, 2015, 101 (23) :1881-1888.
                                    </a>
                                </li>
                                <li id="21">


                                    <a id="bibliography_9" title="Tsutamoto T, Wada A, Maeda K, et al.Plasma brain natriuretic peptide level as a biochemical marker of morbidity and mortality in patients with asymptomatic or minimally symptomatic left ventricular dysfunction.Comparison with plasma angiotension II and endothelin-1[J].Eur Heart J, 1999, 20 (24) :1799-1807." target="_blank"
                                       href="http://scholar.cnki.net/result.aspx?q=Plasma brain natriuretic peptide level as a biochemical marker of morbidity and mortality in patients with asymptomatic or minimally symptomatic left ventricular dysfunction. Comparison with plasma angiotensin II and endothelin-1">
                                        <b>[9]</b>
                                        Tsutamoto T, Wada A, Maeda K, et al.Plasma brain natriuretic peptide level as a biochemical marker of morbidity and mortality in patients with asymptomatic or minimally symptomatic left ventricular dysfunction.Comparison with plasma angiotension II and endothelin-1[J].Eur Heart J, 1999, 20 (24) :1799-1807.
                                    </a>
                                </li>
                                <li id="23">


                                    <a id="bibliography_10" title="Yu CM, Sanderson JE.Plasma brain natriuretic peptide:an independent predictor of cardiovascular mortality in acute heart failure[J].Eur J Heart Fail, 1999, 1 (1) :1790-1799." target="_blank"
                                       href="http://scholar.cnki.net/result.aspx?q=Plasma brain natriuretic peptide - an independent predictor of cardiovascular mortality in acute heart failure">
                                        <b>[10]</b>
                                        Yu CM, Sanderson JE.Plasma brain natriuretic peptide:an independent predictor of cardiovascular mortality in acute heart failure[J].Eur J Heart Fail, 1999, 1 (1) :1790-1799.
                                    </a>
                                </li>
                                <li id="25">


                                    <a id="bibliography_11" title="Kitada S, Kikuchi S, Tsujino T, et al.The prognostic value of brain natriuretic peptide in patients with heart failure and left ventricular ejection fraction higher than 60%:a sub-analysis of the J-MELODIC study[J].ESC Heart Fail, 2018, 5 (1) :36-45." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=SJWD&amp;filename=SJWD92559FE346A9B42938160DF84827DB7F&amp;v=MjI2NDVmcEdZTzErQlE0OXpSOFE0ajU3U0F1VXBCWTllN1hnTjczcENPTnZGU2lXV3I3SklGcG1hQnVIWWZPR1FsZkJyTFUwNXRCaHhMMjJ3NjQ9TmlmY2FycTZHOVRGMg==&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[11]</b>
                                        Kitada S, Kikuchi S, Tsujino T, et al.The prognostic value of brain natriuretic peptide in patients with heart failure and left ventricular ejection fraction higher than 60%:a sub-analysis of the J-MELODIC study[J].ESC Heart Fail, 2018, 5 (1) :36-45.
                                    </a>
                                </li>
                            </ul>
                            <div style='display: none;' class="zqscroller" >
                                <h4 class="">附加材料</h4>
                                <ul></ul>
                            </div>
                        </div>
                    </div>
                </div>
            </div>
            &nbsp;
            <!--此处有一空格符 勿删-->
        </div>

        
    <div class="content">



        <!--tips start-->
                            <div class="tips">
                    <a href="http://navi.cnki.net/KNavi/JournalDetail?pcode=CJFD&amp;pykm=XXGK" target="_blank">心血管康复医学杂志</a>
                2019,28(04),410-414 DOI:10.3969/j.issn.1008-0074.2019.04.06            </div>
        <!--tips end-->
            <div class="top-title">
                <h1 class="title">
                    <span class="vm"><b>血浆脑钠肽对左室射血分数保留的慢性心力衰竭患者预后的预测价值</b></span>
                                    </h1>

            </div>
                        <h2>
                                <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=au&amp;skey=%E9%99%88%E7%88%B1%E5%8D%8E&amp;code=08966223&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">陈爱华</a>
                                <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=au&amp;skey=%E7%AB%A0%E5%AE%8F%E7%A5%A5&amp;code=42560797&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">章宏祥</a>
                </h2>
                    <h2>
                    <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=in&amp;skey=%E7%9A%96%E5%8D%97%E5%8C%BB%E5%AD%A6%E9%99%A2%E7%AC%AC%E4%BA%8C%E9%99%84%E5%B1%9E%E5%8C%BB%E9%99%A2%E5%BF%83%E5%86%85%E7%A7%91&amp;code=0125850&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">皖南医学院第二附属医院心内科</a>
            </h2>

        
<div class="link">
    <a id="aexport" class="icon icon-output"  onclick="" href="javascript:void(0);"><i></i>导出/参考文献</a>
    
    <span class="shareBoard" onmouseover="$('#sharedet').show();$('#this').addClass('shareBoardCUR')" onmouseout="$('#sharedet').hide();$('#this').removeClass('shareBoardCUR')">
        <a class="icon icon-share" href="#"><i></i>分享<em></em></a>
        <ul class="shareHide" id="sharedet" style="display: none;">
            <li><a title="复制链接" class="copy" onclick="" href="#"><i></i>复制链接</a></li>
            <li><a title="分享到新浪微博" class="xl" onclick="" href="javascript:common.ShareAction('xl');"><i></i>新浪微博</a></li>
            <li>
                <a title="分享到微信" class="wx" onclick="" href="#"><i></i>微信扫一扫</a>
                <div class="qrcode"><img src='' alt='' /></div>
            </li>
        </ul>

    </span>
    
    <a id="RefTrack" title="创建引文跟踪" class="icon icon-track" onclick="" href="javascript:void(0);"> <i></i>创建引文跟踪 </a>
    <a id="ashoucang" title="收藏" class="icon icon-favor" onclick="" href="javascript:void(0);"><i></i>收藏</a>
    <a class="icon icon-print" onclick="window.print();" href="javascript:void(0);"><i></i>打印</a>
    
    <!--版本切换 end-->
</div>
                            <div class="data" id="a_abstract">
                <span class="keys">摘<span style="font-family: 'Times New Roman';">&nbsp;&nbsp;&nbsp;&nbsp;</span>要：</span>
                <p><b>目的</b>:观察血浆脑钠肽 (BNP) 对左室射血分数保留的慢性心力衰竭 (HFpEF) 患者的预测价值。<b>方法</b>:2014年～2016年我院CHF患者122例, 根据LVEF, 患者被分为LVEF减低心衰 (HFrEF) 组 (LVEF≤40%, 41例) 、中间值LVEF心衰 (HFmEF) 组 (40%&lt;LVEF&lt;50%, 40例) 和HFpEF组 (LVEF≥50%, 41例) 。收集、测量比较三组临床资料、血浆BNP水平等指标;ROC曲线分析血浆BNP预测CHF患者短期主要不良终点事件 (SMAE) 的界值和价值;COX风险回归模型分析预测上述三组SMAE的危险因素。<b>结果</b>:LVEDd:HFpEF组&lt;HFmEF组&lt;HFrEF组, 两两比较均有显著差异, <i>P</i>均=0.001。HFpEF组、HFmEF组LAD显著大于HFrEF组, <i>P</i>均&lt;0.05。与HFpEF组比较, HFmEF组和HFrEF组的血浆BNP[ (789.39±455.62) pg/ml比 (1143.40±567.99) pg/ml比 (2341.51±1029.99) pg/ml]水平显著升高, 且HFrEF组的显著高于HFmEF组, <i>P</i>均&lt;0.01。多因素Logistic回归结果显示血浆BNP水平是HFmEF、HFrEF患者SMAE事件的独立危险因素 (OR=1.006, 1.001, <i>P</i>均&lt;0.05) 。ROC曲线分析显示, 血浆BNP预测CHF患者SMAE的AUC=0.818, 界值为1415pg/ml, 敏感度和特异度分别为82.6%和72.7%。三组间住院期间及出院后12个月随访期内的再住院及死亡率无显著差异, <i>P</i>=0.328。<b>结论</b>:血浆BNP对HFmEF和HFrEF患者的短期再入院和死亡事件有良好的预测价值, 但不能预测HFpEF患者的终点事件。</p>
            </div>
                    <div class="data" id="a_keywords">
                <span class="keys">关键词：</span>
                <p>
                        <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=kw&amp;skey=%E5%BF%83%E5%8A%9B%E8%A1%B0%E7%AB%AD&amp;code=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">心力衰竭;</a>
                        <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=kw&amp;skey=%E5%88%A9%E9%92%A0%E8%82%BD%2C%20%E8%84%91&amp;code=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">利钠肽, 脑;</a>
                        <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=kw&amp;skey=%E9%A2%84%E5%90%8E&amp;code=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">预后;</a>
                </p>
            </div>
        
        <!--brief start-->
        
            <div class="brief">
                    <p>
                            <b>作者简介：</b>
                                                        <span>
                                    *章宏祥, E-mail:zhang_hxx@126.com;
                                </span>
                    </p>
                                    <p><b>收稿日期：</b>2018-02-01</p>

            </div>
                    <h1>Predictive value of plasma BNP for prognosis in patients with chronic heart failure preserved ejection fraction</h1>
                    <h2>
                    <span>CHEN Ai-hua</span>
                    <span>ZHANG Hong-xiang</span>
            </h2>
                    <h2>
                    <span>Department of Cardiology, Second Affiliated Hospital of Wannan Medical College</span>
            </h2>
                            <div class="data" id="a_abstractEN">
                <span class="keys">Abstract：</span>
                <p><b>Objective</b>:To observe predictive value of plasma brain natriuretic peptide (BNP) for prognosis in patients with chronic heart failure preserved left ventricular ejection fraction (HFpEF) .<b>Methods</b>:A total of 122 CHF patients from 2014 to 2016, according to LVEF, patients were divided into LVEF reduced HF (HFrEF) group (LVEF≤40%, n=41) , HF with medium LVEF (HFmEF) group (40%&lt;LVEF&lt;50%, n=40) and HFpEF group (LVEF≥50%, n=41) . Clinical data, plasma BNP level etc. were measured and compared among three groups; ROC was used to analyze cutoff point of plasma BNP predicting short-term major adverse endpoint (SMAE) in CHF patients. <b>Results</b>:For LVEDd, HFpEF grou<i>P</i>&lt;HFmEF group&lt;HFrEF group, there existed significant difference between any two groups, <i>P</i>=0.001 all. Left atrial diameter (LAD) of HFpEF group and HFmEF group were significantly higher than that of HFrEF group, <i>P</i>&lt;0.05 both. Compared with HFpEF group, there was significant rise in plasma BNP level [ (789.39±455.62) pg/ml vs. (1143.40±567.99) pg/ml vs. (2341.51±1029.99) pg/ml] in HFmEF group and HFrEF group, and that of HFrEF group was significantly higher than that of HFmEF group, <i>P</i>&lt;0.01 all. Multifactor Logistic regression indicated that plasma BNP level was independent risk factor for SMAE events in HFmEF and HFrEF patients (OR=1.006, 1.001, <i>P</i>&lt;0.05 both) . ROC analysis indicated that AUC of plasma BNP predicting SMAE in CHF patients was 0.818, cutoff point was 1415 pg/ml, and sensitivity and specificity was 82.6% and 72.7% respectively. There was no significant difference in rehospitalization rate and mortality during hospitalization and within 12-month follow-up after discharge among three groups, <i>P</i>=0.328. <b>Conclusion</b>:Plasma BNP possesses good predictive value for short-term rehospitalization and death events in HFmEF and HFrEF patients, but it can′t predict endpoint events of HFpEF patients.</p>
            </div>
                    <div class="data" id="a_keywordsEN">
                <span class="keys">Keyword：</span>
                <p>
                        <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=kw&amp;skey=Heart%20failure&amp;code=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">Heart failure;</a>
                        <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=kw&amp;skey=Natriuretic%20peptide%2C%20brain&amp;code=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">Natriuretic peptide, brain;</a>
                        <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=kw&amp;skey=Prognosis&amp;code=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">Prognosis;</a>
                </p>
            </div>
                    <div class="brief">
                
                    <p>
                            <b>Author：</b>
                                                        <span>
                                    ZHANG Hong-xiang, E-mail:zhang_hxx@126.com;
                                </span>
                    </p>
                                    <p><b>Received：</b> 2018-02-01</p>
                            </div>


        <!--brief start-->
                        <div class="p1">
                    <p id="27">临床上, 心力衰竭 (HF) 患者中有几乎50%的患者LVEF没有显著下降, 也就是我们通常所说的射血分数保留的心力衰竭 (HFpEF) 。近年来, 随着药物的规范化治疗和对部分患者器械植入治疗, 射血分数降低的心力衰竭 (HFrEF) 患者的发病率和死亡率已经有所改善, 但是, HFpEF患者的发病率及死亡率依然没有变化<citation id="61" type="reference"><link href="5" rel="bibliography" /><link href="7" rel="bibliography" /><sup>[<a class="sup">1</a>,<a class="sup">2</a>]</sup></citation>。HFpEF的患者具有心力衰竭的表现, 左室射血分数 (LVEF) ≥50%, 即使在左室收缩功能正常的情况下, 也会表现为左室舒张功能障碍。多个研究表明, 应用心脏超声和 (或) 心脏磁共振检查发现, 左室收缩功能受损的HFpEF患者中, 有些患者LVEF的水平也比50%高得多<citation id="62" type="reference"><link href="9" rel="bibliography" /><link href="11" rel="bibliography" /><link href="13" rel="bibliography" /><sup>[<a class="sup">3</a>,<a class="sup">4</a>,<a class="sup">5</a>]</sup></citation>。因此, 有理由推测, 通常的HFpEF的分类判断并不能仅仅依据患者心衰的临床特征和他们的LVEF。</p>
                </div>
                <div class="p1">
                    <p id="28">脑钠肽又称B型利钠肽 (BNP) , 主要来源于心室, 研究表明人血中的BNP是由左心室心肌细胞合成和分泌的, 正常状态下在心室储备很少, 刺激BNP分泌的主要条件是心室负荷和室壁张力的改变<citation id="64" type="reference"><link href="15" rel="bibliography" /><link href="17" rel="bibliography" /><sup>[<a class="sup">6</a>,<a class="sup">7</a>]</sup></citation>。研究表明, BNP与充血性心力衰竭 (CHF) 的严重程度呈正相关。另外, 国外有文献报道<citation id="63" type="reference"><link href="19" rel="bibliography" /><sup>[<a class="sup">8</a>]</sup></citation>, 升高的BNP水平与HFrEF的不良预后有关, 但是, BNP水平不能预测HFpEF患者的心血管事件。国内目前少有文献报道BNP对HFpEF患者预后的价值。本课题主要研究不同LVEF水平HF患者临床特征的差异和BNP对HFpEF患者预后的价值。</p>
                </div>
                <h3 id="29" name="29" class="anchor-tag"><b>1 资料与方法</b></h3>
                <h4 class="anchor-tag" id="30" name="30">1.1 一般资料</h4>
                <div class="p1">
                    <p id="31">选择2014年7月～2016年7月住院期间确诊CHF患者122例。其中男性62例, 女性60例, 年龄40～80 (68.00±7.98) 岁。基础心脏病包括冠心病55例 (45.08%) , 瓣膜性心脏病7例 (5.74%) , 扩张型心肌病25例 (20.49%) , 肥厚性心肌病6例 (4.92%) , 高血压性心脏病29例 (23.77%) 。排除标准:严重感染, 严重肝、肾功能不全, 急性冠脉综合征, 植入埋藏式心脏转复除颤器, 肿瘤, 结缔组织病, 血液病, 甲状腺疾病, 原发性醛固酮增多症等内分泌疾病。心功能按纽约心脏协会 (NYHA) 分级, 其中心功能Ⅱ级26例, 心功能Ⅲ级47例, 心功能Ⅳ级49例。观察、随访心衰患者在住院期间与出院后12个月内再住院和死亡情况。</p>
                </div>
                <h4 class="anchor-tag" id="32" name="32">1.2 研究设计</h4>
                <div class="p1">
                    <p id="33">本研究中, 患者根据LVEF的值被分为三组:HFrEF组 (LVEF≤40%, 41例) , 射血分数中间值心力衰竭 (HFmEF) 组 (40%&lt;LVEF&lt;50%, 40例) , HFpEF组 (LVEF≥50%, 41例) 。本研究不仅比较HFrEF组、HFmEF组和HFpEF组之间的临床资料特征的差异, 同时, 还比较了BNP对每组患者预后的影响。</p>
                </div>
                <h4 class="anchor-tag" id="34" name="34">1.3 标本采集及血BNP测定</h4>
                <div class="p1">
                    <p id="35">所有患者常规检查心率、血压, 并行电解质、肾功能、血糖、甘油三酯、总胆固醇等生化检查, 入院后即刻抽取患者静脉血1ml放入乙二胺四乙酸 (EDTA) 抗凝管中, 用吸管吸入样本血液, 将吸管中的血液加入到检测板上方的加样孔, 随后将检测板插入Triage Meterplus免疫荧光分析仪进行分析。</p>
                </div>
                <h4 class="anchor-tag" id="36" name="36">1.4 超声心动图</h4>
                <div class="p1">
                    <p id="37">住院后24h内完成超声心动图检查, 应用的仪器为SONOS 5500 (Phlips 公司, 荷兰) 多普勒彩色超声诊断仪, 探头频率为2.5MHz进行检查。由经验丰富的彩超室医生测量左心室舒张末内径 (LVEDd) 、左室收缩末内径 (LVESd) 、LVEF、二尖瓣、三尖瓣返流等数据。</p>
                </div>
                <h4 class="anchor-tag" id="38" name="38">1.5 短期主要不良终点事件 (SMAE) 的判定</h4>
                <div class="p1">
                    <p id="39">SMAE事件是指患者住院期间及出院后12个月随访期间发生的再住院和死亡。 观察的时间指从患者入选开始到出现不良事件那一天止, 或者患者无不良事件生存到随访结束的时间。</p>
                </div>
                <h4 class="anchor-tag" id="40" name="40">1.6 统计学方法</h4>
                <div class="p1">
                    <p id="41">所有数据采用SPSS 19.0统计软件对数据进行统计分析。计量资料以均数±标准差 (<image id="68" type="formula" href="images/XXGK201904006_06800.jpg" display="inline" placement="inline"><alt></alt></image>±s) 表示, 用独立<i>t</i>检验或Mann-Whitney U检验比较两组数据之间的判别, 单因素方差分析比较三组间的差异, 比较采用<i>t</i>检验, 计数资料以百分率表示, 比较采用<i>χ</i><sup>2</sup>检验。多因素Logistic回归分析CHF复合终点的危险因素。ROC曲线分析BNP对所有CHF患者终点事件的预测价值。<i>P</i>&lt;0.05为差异具有统计学意义。</p>
                </div>
                <h3 id="43" name="43" class="anchor-tag"><b>2 结 果</b></h3>
                <h4 class="anchor-tag" id="44" name="44">2.1 基线资料</h4>
                <div class="p1">
                    <p id="45">三组患者在年龄、性别、吸烟史、血压、血糖、总胆固醇、甘油三酯、低密度脂蛋白-胆固醇、药物使用、血肌酐等基线资料方面无显著差别 (<i>P</i>均&gt;0.05) 。三组间LVEDd, HFpEF组&lt;HFmEF组&lt;HFrEF组, 两两比较有显著差异 (<i>P</i>均=0.001) 。HFpEF组、HFmEF组左房内径显著大于HFrEF组 (<i>P</i>均&lt;0.05) 。见表1。</p>
                </div>
                <div class="area_img" id="46">
                    <p class="img_tit"><b>表</b>1 <b>三组患者的基线资料比较</b> <a class="downexcel" onclick="DownLoadReportExcel(this)">导出到EXCEL</a></p>
                    <p class="img_tit"></p>
                    <p class="img_note"></p>
                    <table id="46" border="1"><tr><td><br /></td><td>HFpEF组<br /> (n=41) </td><td>HFmEF组<br /> (n=40) </td><td>HFrEF组<br /> (n=41) </td><td><i>F</i>/<i>χ</i><sup>2</sup></td><td><i>P</i></td><td><i>P</i><sub><i>p</i>, <i>m</i></sub></td><td><i>P</i><sub><i>p</i>, <i>r</i></sub></td><td><i>P</i><sub><i>m</i>, <i>r</i></sub></td></tr><tr><td><br />年龄 (岁) </td><td>68.20±7.98</td><td>67.90±7.95</td><td>68.50±8.02</td><td>0.570</td><td>0.567</td><td></td><td></td><td></td></tr><tr><td><br />男性<i>n</i> (%) </td><td>19 (46.34) </td><td>22 (55.00) </td><td>21 (51.22) </td><td>0.606</td><td>0.738</td><td></td><td></td><td></td></tr><tr><td><br />吸烟<i>n</i> (%) </td><td>8 (19.51) </td><td>9 (22.50) </td><td>9 (21.95) </td><td>0.075</td><td>0.963</td><td></td><td></td><td></td></tr><tr><td><br />收缩压 (mmHg) </td><td>146.13±23.69</td><td>133.43±21.72</td><td>140.69±31.64</td><td>2.161</td><td>0.126</td><td></td><td></td><td></td></tr><tr><td><br />舒张压 (mmHg) </td><td>82.75±10.45</td><td>82.85±13.58</td><td>82.83±9.63</td><td>0.006</td><td>0.994</td><td></td><td></td><td></td></tr><tr><td><br />血糖 (mmol/L) </td><td>6.45±1.67</td><td>5.48±1.35</td><td>5.40±1.70</td><td>2.575</td><td>0.080</td><td></td><td></td><td></td></tr><tr><td><br />总胆固醇 (mmol/L) </td><td>4.50±1.24</td><td>4.36±1.22</td><td>4.67±1.15</td><td>0.788</td><td>0.457</td><td></td><td></td><td></td></tr><tr><td><br />甘油三酯 (mmol/L) </td><td>1.02±0.54</td><td>1.22±0.98</td><td>1.18±0.76</td><td>1.792</td><td>0.171</td><td></td><td></td><td></td></tr><tr><td><br />低密度脂蛋白-胆固醇 (mmol/L) </td><td>3.25±0.54</td><td>3.18±0.58</td><td>3.27±0.47</td><td>0.297</td><td>0.744</td><td></td><td></td><td></td></tr><tr><td><br />血肌酐 (μmol/L) </td><td>118±22</td><td>124±28</td><td>115±27</td><td>0.897</td><td>0.411</td><td></td><td></td><td></td></tr><tr><td><br />ACEI或ARB <i>n</i> (%) </td><td>40 (97.56) </td><td>40 (100) </td><td>41 (100) </td><td>1.021</td><td>0.600</td><td></td><td></td><td></td></tr><tr><td><br />β-受体阻滞剂<i>n</i> (%) </td><td>38 (92.68) </td><td>38 (95.00) </td><td>36 (87.80) </td><td>1.445</td><td>0.486</td><td></td><td></td><td></td></tr><tr><td><br />利尿剂<i>n</i> (%) </td><td>35 (85.37) </td><td>37 (92.50) </td><td>38 (92.68) </td><td>1.170</td><td>0.557</td><td></td><td></td><td></td></tr><tr><td><br />左室舒张末内径 (mm) </td><td>48.2±6.1<sup>△△▲▲</sup></td><td>53.9±7.6<sup>△△</sup></td><td>60.6±7.9</td><td>30.132</td><td>0.001</td><td>0.001</td><td>0.001</td><td>0.001</td></tr><tr><td><br />左房内径 (mm) </td><td>45.4±8.5<sup>△</sup></td><td>44.8±8.3<sup>△</sup></td><td>41.3±6.6</td><td>3.261</td><td>0.042</td><td>0.749</td><td>0.017</td><td>0.039</td></tr></table>
                    <form name="form" action="/kxreader/Detail/DownloadReportExcel" method="POST" style="display:inline">
                        <input type="hidden" name="hidTable" value="" />
                        <input type="hidden" name="hidFileName" value="" />
                    </form>
                    <p class="img_note">注:ACEI:血管紧张素转换酶抑制剂, ARB:血管紧张素II受体拮抗剂, HFpEF:射血分数保留心力衰竭, HFmEF:射血分数中间值心力衰竭, HFrEF:射血分数降低心力衰竭。与HFrEF组比较△<i>P</i>&lt;0.05, △△<i>P</i>&lt;0.01;与HFmEF组比较▲▲P&lt;0.01。下表同。</p>
                    <p class="img_note"></p>
                </div>
                <h4 class="anchor-tag" id="47" name="47">2.2 三组患者血浆BNP水平比较</h4>
                <div class="p1">
                    <p id="48">三组间血浆BNP水平比较:HFpEF组&lt;HFmEF组&lt;HFrEF组, 两两之间比较有显著差异 (<i>P</i>均&lt;0.01) 。见表2。</p>
                </div>
                <div class="area_img" id="49">
                    <p class="img_tit">表2 三组患者血浆脑钠肽水平比较（<image id="69" type="formula" href="images/XXGK201904006_06900.jpg" display="inline" placement="inline"><alt></alt></image>±s)  <a class="downexcel" onclick="DownLoadReportExcel(this)">导出到EXCEL</a></p>
                    <p class="img_tit"></p>
                    <p class="img_note"></p>
                    <table id="49" border="1"><tr><td><br /></td><td>HFpEF组<br /> (n=41) </td><td>HFmEF组<br /> (n=40) </td><td>HFrEF组<br /> (n=41) </td><td><i>F</i></td><td><i>P</i></td></tr><tr><td><br />血浆脑钠肽 (pg/ml) </td><td>789.39±455.62<sup>△△▲▲</sup></td><td>1143.40±567.99<sup>△△</sup></td><td>2341.51±1029.99</td><td>58.579</td><td>0.001</td></tr></table>
                    <form name="form" action="/kxreader/Detail/DownloadReportExcel" method="POST" style="display:inline">
                        <input type="hidden" name="hidTable" value="" />
                        <input type="hidden" name="hidFileName" value="" />
                    </form>
                    <p class="img_note"></p>
                    <p class="img_note">注:HFpEF vs HFmEF, <i>P</i>=0.003;HFpEF vs HFrEF, <i>P</i>=0.001;HFmEF vs HFrEF <i>P</i>=0.001。</p>
                </div>
                <h4 class="anchor-tag" id="51" name="51">2.3 CHF患者的临床基线特征与SMAE的相关性</h4>
                <div class="p1">
                    <p id="52">表3显示在所有临床基线特征中, 通过Logistic多因素回归显示血浆BNP是HFmEF组、HFrEF组患者SMAE事件的独立危险因素 (OR=1.006, 1.001, <i>P</i>均&lt;0.05) , 但不能预测HFpEF组的SMAE事件 (OR=1.005, <i>P</i>=0.243) 。应用ROC曲线图分析血浆BNP对所有CHF患者终点事件的预测价值。图1中ROC曲线图显示, 血浆BNP的曲线下面积为0.818, 95%可信区间为 (0.733, 0.903) (<i>P</i>=0.001) 。通过约登指数计算出CHF的患者发生SMAE的血浆BNP的临界值 (cut-off point) 为1415pg/ml, 预测住院期间及出院后12个月内SMAE的敏感度为82.6%, 特异度为72.7%。</p>
                </div>
                <div class="p1">
                    <p id="53">该研究结果中, HFpEF组随访期间再入院5例, 无死亡病例。HFmEF组随访期间再入院9例, 其中1例患者因CHF急性加重再入院, 住院期间因顽固性心力衰竭不能纠正而死亡。HFrEF组随访期间再入院10例, 1例在随访第182d在家死亡。三组间再入院率无显著性差异 (<i>P</i>=0.244) 。见表4。</p>
                </div>
                <div class="area_img" id="54">
                    <p class="img_tit"><b>表</b>3 HFrEF、HFmEF、HFpEF<b>组</b>BNP<b>及基线资料与患者短期主要不良终点事件的相关性</b> <a class="downexcel" onclick="DownLoadReportExcel(this)">导出到EXCEL</a></p>
                    <p class="img_tit"></p>
                    <p class="img_note"></p>
                    <table id="54" border="1"><tr><td rowspan="2"></td><td rowspan="2">单因素<br /><i>P</i></td><td colspan="2"><br />HFpEF多因素</td><td rowspan="2">单因素<br /><i>P</i></td><td colspan="2"><br />HFmEF多因素</td><td rowspan="2">单因素<br /><i>P</i></td><td colspan="2"><br />HFrEF多因素</td></tr><tr><td><br />OR (95%CI) </td><td><i>P</i></td><td><br />OR (95%CI) </td><td><i>P</i></td><td><br />OR (95%CI) </td><td><i>P</i></td></tr><tr><td>血浆脑钠肽 (pg/ml) </td><td>0.191</td><td>1.005 (0.996～1.014) </td><td>0.243</td><td>0.001</td><td>1.006 (1.000～1.012) </td><td>0.036</td><td>0.002</td><td>1.001 (1.000～1.003) </td><td>0.027</td></tr><tr><td><br />年龄 (岁) </td><td>0.874</td><td>0.911 (0.723～1.147) </td><td>0.427</td><td>0.616</td><td>0.873 (0.695～1.096) </td><td>0.241</td><td>0.225</td><td>1.090 (0.970～1.224) </td><td>0.147</td></tr><tr><td><br />女性</td><td>0.409</td><td>0.028 (0.000～23.80) </td><td>0.300</td><td>0.893</td><td>0.328 (0.014～7.712) </td><td>0.489</td><td>0.343</td><td>0.141 (0.013～1.517) </td><td>0.106</td></tr><tr><td><br />高血压</td><td>0.261</td><td>648.19 (0.015～27343423.44) </td><td>0.233</td><td>0.705</td><td>1.638 (0.147～18.184) </td><td>0.688</td><td>0.385</td><td>4.040 (0.363～45.026) </td><td>0.256</td></tr><tr><td><br />糖尿病</td><td>0.708</td><td>0.009 (0.000～178.120) </td><td>0.349</td><td>0.470</td><td>14.132 (0.408～489.132) </td><td>0.143</td><td>0.411</td><td>0.220 (0.020～2.380) </td><td>0.213</td></tr><tr><td><br />吸烟</td><td>0.834</td><td>6.619 (0.076～579.041) </td><td>0.407</td><td>0.096</td><td>7.125 (0.263～192.895) </td><td>0.243</td><td>0.343</td><td>2.039 (0.248～16.794) </td><td>0.508</td></tr><tr><td><br />肌酐 (μmol/L) </td><td>0.752</td><td>0.956 (0.888～1.029) </td><td>0.230</td><td>0.530</td><td>1.040 (0.989～1.093) </td><td>0.129</td><td>0.643</td><td>1.001 (0.970～1.034) </td><td>0.939</td></tr><tr><td><br />LVEF (%) </td><td>0.575</td><td>0.953 (0.733～1.239) </td><td>0.719</td><td>0.112</td><td>1.282 (0.889～1.850) </td><td>0.183</td><td>0.580</td><td>0.942 (0.662～1.342) </td><td>0.742</td></tr><tr><td><br />ACEI和ARB</td><td>0.776</td><td></td><td>1.000</td><td></td><td></td><td>1.000</td><td>0.180</td><td></td><td>1.000</td></tr><tr><td><br />β受体阻滞剂</td><td>0.613</td><td></td><td>1.000</td><td>0.434</td><td></td><td>1.000</td><td>0.430</td><td></td><td>1.000</td></tr><tr><td><br />利尿剂</td><td>0.456</td><td></td><td>1.000</td><td>0.332</td><td></td><td>1.000</td><td>0.680</td><td></td><td>1.000</td></tr></table>
                    <form name="form" action="/kxreader/Detail/DownloadReportExcel" method="POST" style="display:inline">
                        <input type="hidden" name="hidTable" value="" />
                        <input type="hidden" name="hidFileName" value="" />
                    </form>
                    <p class="img_note"></p>
                    <p class="img_note"></p>
                </div>
                <div class="area_img" id="55">
                    <p class="img_tit"><b>表</b>4 HFrEF、HFmEF、HFpEF<b>三组患者再入院率比较</b> <a class="downexcel" onclick="DownLoadReportExcel(this)">导出到EXCEL</a></p>
                    <p class="img_tit"></p>
                    <p class="img_note"></p>
                    <table id="55" border="1"><tr><td><br /></td><td>HFpEF组<br /> (n=41) </td><td>HFmEF组<br /> (n=40) </td><td>HFrEF组<br /> (n=41) </td><td><i>χ</i><sup>2</sup></td><td><i>P</i></td></tr><tr><td><br />再入院率<i>n</i> (%) </td><td>5 (12.2) </td><td>9 (22.5) </td><td>10 (24.4) </td><td>2.819</td><td>0.244</td></tr></table>
                    <form name="form" action="/kxreader/Detail/DownloadReportExcel" method="POST" style="display:inline">
                        <input type="hidden" name="hidTable" value="" />
                        <input type="hidden" name="hidFileName" value="" />
                    </form>
                    <p class="img_note"></p>
                    <p class="img_note"></p>
                </div>
                <div class="area_img" id="56">
                                <a class="zoom-in" href="Detail/GetImg?filename=images/XXGK201904006_056.jpg&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                    <img alt="图1 血浆BNP预测终点事件的ROC曲线" src="Detail/GetImg?filename=images/XXGK201904006_056.jpg&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" />
                                </a>
                                <p class="img_tit"><b>图</b>1 <b>血浆</b>BNP<b>预测终点事件的</b>ROC<b>曲线</b>  <a class="btn-zoomin" href="Detail/GetImg?filename=images/XXGK201904006_056.jpg&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!"></a><a class="downimg">&nbsp;&nbsp;下载原图</a></p>
                            <p class="img_tit"></p>

                </div>
                <h3 id="57" name="57" class="anchor-tag"><b>3 讨 论</b></h3>
                <div class="p1">
                    <p id="58">本研究为随机性、前瞻性研究。Logistic多因素回归分析发现, 在年龄、性别、高血压、LVEF、血浆BNP等多因素中, 只有血浆BNP可预测HFmEF及HFrEF的患者SMAE事件, 但是, 血浆BNP不能预测HFpEF患者的终点事件。血浆BNP预测CHF患者终点事件的切点值是1415pg/ml。本研究还发现, HFpEF患者和HFmEF患者的左房内径显著大于HFrEF的患者 (<i>P</i>均&lt;0.05) 。</p>
                </div>
                <div class="p1">
                    <p id="59">BNP是含 32个氨基酸的多肽, 主要由心室细胞分泌, 在血容量和心室压力增加前提下分泌的肽类激素, 血浆BNP与左室舒张末压力有良好的相关性。它可以促进利钠、排尿, 具有较强的舒张血管作用, 可对抗肾素-血管紧张素-醛固酮系统的收缩血管作用。近年来国内外关于BNP的研究很多, 在心功能不全时血浆BNP浓度显著升高, 而且其浓度与心衰程度呈正相关。Tsutamot<citation id="65" type="reference"><link href="21" rel="bibliography" /><sup>[<a class="sup">9</a>]</sup></citation>等对85例心衰患者平均随访27个月, 24例死于心脏疾病, 死亡患者的 BNP水平 (436±82) pg/ml 显著高于存活者 (89±15) pg/ml, 以56pg/ml 为基准点, BNP水平每增加10pg/ml, 2年内的死亡风险则增加4%。但是, 本研究的结果表明, BNP预测再入院和死亡的切点值显著高于Tsutamot等的BNP水平, 为1415pg/ml。Yu<citation id="66" type="reference"><link href="23" rel="bibliography" /><sup>[<a class="sup">10</a>]</sup></citation>等的观测表明BNP水平是12个月内心源性死亡的良好预测指标, 其准确性高于年龄、性别、左心室射血分数、心脏病病因和 NYHA分级。和Yu等的研究相比, 本研究不仅计算出血浆BNP预测心衰患者不良事件的切点值, 同时发现, 血浆BNP是HFrEF和HFmEF心衰患者终点事件的独立预测因子, 但是, 血浆BNP不能预测HFpEF患者的终点事件, 这可能的原因是HFpEF的患者血浆BNP水平相对较低, 未达到BNP的切点值。本研究中发现, 在所有基线临床资料中, 左房内径增大可能是HFpEF患者的危险因素, 而在Kitada S等<citation id="67" type="reference"><link href="25" rel="bibliography" /><sup>[<a class="sup">11</a>]</sup></citation>的研究中, HFpEF的高危因素, 除了左房增大以外, 还与老年, 女性, 高血压, 房颤等因素有关。本研究样本量相对较小, 可能是导致与Kitada S等的研究结论差别的原因。</p>
                </div>
                <div class="p1">
                    <p id="60">LVEF对预后的影响在许多研究中都有相同的结论, 即LVEF越低, 死亡率越高, 经治疗后LVEF显著升高的患者预后会好于无改变的患者。Mcdonag等的研究显示LVEF&lt;0.4的心衰患者, 4年死亡率为9.8%, 而LVEF&gt; 0.4者, 4年死亡率为3.4% (<i>P</i>=0.001) 。本研究中发现, LVEF与CHF患者的预后无显著关系, 而血浆BNP是HFmEF、HFrEF患者发生SMAE的独立危险因素。LVEF的对患者预后预测的差异性可能源于各个中心测量方法的不同, 或测量的误差有关, 样本量较少也有可能影响研究的结果。本研究的结论需要更多中心及更大样本量的研究来证实。</p>
                </div>

        <!--brief end-->
        
        <!--conten left  end-->
        <!--增强附件-->
        

        <!--reference start-->
            <div class="reference anchor-tag" id="a_bibliography">
                    <h3>参考文献</h3>
                                        <p id="5">
                            <a id="bibliography_1" target="_blank" href="http://scholar.cnki.net/result.aspx?q=Outcome of heart failure with preserved ejection fraction in a population-based study">

                                <b>[1]</b>Bhatia RS, Tu JV, Lee DS, et al.Outcome of heart failure with preserved ejection fraction in a population-based study[J].N Engl J Med, 2006, 355 (3) :260-269.
                            </a>
                        </p>
                        <p id="7">
                            <a id="bibliography_2" target="_blank" href="/kcms/detail/detail.aspx?dbcode=SJRS&amp;filename=SJRS120719010560&amp;v=MDkwOTd0Yk5wbzlFWk80SkRCTTh6eFVTbURkOVNIN24zeEU5ZmJ2bktyaWZaZVp2RnludFU3L05LVjBTTmlmWmZiSzZI&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[2]</b>Steinberg BA, Zhao X, Heidenreich PA, et al.Trends in patients hospitalized with heart failure and preserved left ventricular ejection fraction:prevalence, therapies, and outcomes[J].Circulation, 2012, 126 (1) :65-75.
                            </a>
                        </p>
                        <p id="9">
                            <a id="bibliography_3" target="_blank" href="/kcms/detail/detail.aspx?dbcode=SJES&amp;filename=SJES13012300501433&amp;v=MTQ0NTAvaXJSZEdlcnFRVE1ud1plWnRGaW5sVXJmSUlGc2RhUlE9TmlmT2ZiSzdIdERPckk5Rlllc09DSDg2b0JNVDZUNFBRSA==&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[3]</b>García EH, Perna ER, Farías EF, et al.Reduced systolic performance by tissue Doppler in patients with preserved and abnormal ejection fraction:new insights in chronic heart failure[J].Int J Cardiol, 2006, 108 (2) :181-188.
                            </a>
                        </p>
                        <p id="11">
                            <a id="bibliography_4" target="_blank" href="/kcms/detail/detail.aspx?dbcode=SJES&amp;filename=SJES13012100340142&amp;v=MjIxMzNIL2lyUmRHZXJxUVRNbndaZVp0RmlubFVyZklJRnNkYVJRPU5pZk9mYks3SHRET3JvOUZaKzhQRFhnN29CTVQ2VDRQUQ==&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[4]</b>Borlaug BA, Lam CS, Roger VL, et al.Contractility and ventricular systolic stiffening in hypertensive heart disease insights into the pathogenesis of heart failure with preserved ejection fraction[J].J Am Coll Cardiol, 2009, 54 (5) :410-418.
                            </a>
                        </p>
                        <p id="13">
                            <a id="bibliography_5" target="_blank" href="/kcms/detail/detail.aspx?dbcode=SJES&amp;filename=SJES13012300055873&amp;v=MjY3ODdkYVJRPU5pZk9mYks3SHRET3JJOUZaTzRLQkhzNm9CTVQ2VDRQUUgvaXJSZEdlcnFRVE1ud1plWnRGaW5sVXJmSUlGcw==&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[5]</b>Kaku K, Takeuchi M, Otani K, et al.Age and gender dependency of left ventricular geometry assessed with real-time three dimensional transthoracic echocardiography[J].J Am Soc Echocardiogr, 2011, 24 (5) :541-547.
                            </a>
                        </p>
                        <p id="15">
                            <a id="bibliography_6" target="_blank" href="/kcms/detail/detail.aspx?dbcode=SJES&amp;filename=SJES82854A0DEA2666D20C6BB8741C679B35&amp;v=MDk3NjY4eEVab05Dbm8vdXhRVG1Ua1BPbmZscUJOR2Y3V2RON21hQ09OdkZTaVdXcjdKSUZwbWFCdUhZZk9HUWxmQnJMVTA1dEJoeEwyMnc2ND1OaWZPZmJ1NkZ0VEkzbw==&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[6]</b>Kainuma S, Taniguchi K, Toda K, et al.B-type natriuretic peptide response and reverse left ventricular remodeling after surgical correction of functional mitral regurgitation in patients with advanced cardiomyopathy[J].J Cardiol, 2015, 66 (4) :279-285.
                            </a>
                        </p>
                        <p id="17">
                            <a id="bibliography_7" target="_blank" href="http://scholar.cnki.net/result.aspx?q=Prognostic importance of exercise brain natriuretic peptide in asymptomatic degenerative mitral regurgitation">

                                <b>[7]</b>Magne J, Mahjoub H, Pibarot P, et al.Prognostic importance of exercise brain natriuretic peptide in asymptomatic degenerative mitral regurgitation[J].Eur J Heart Fail, 2012, 14 (11) :1293-1302.
                            </a>
                        </p>
                        <p id="19">
                            <a id="bibliography_8" target="_blank" href="/kcms/detail/detail.aspx?dbcode=SJRS&amp;filename=SJRS15112000001402&amp;v=MTAwODZ3N29CTVQ2VDRQUUgvaXJSZEdlcnFRVE1ud1plWnRGaW5sVXJmSUlGc2RhUlE9TmlmWmZiSzlIOURPcjQ5RlpPc09DSA==&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[8]</b>Kang SH, Park JJ, Choi DJ, et al.Prognostic value of NTproBNP in heart failure with preserved versus reduced EF[J].Heart, 2015, 101 (23) :1881-1888.
                            </a>
                        </p>
                        <p id="21">
                            <a id="bibliography_9" target="_blank" href="http://scholar.cnki.net/result.aspx?q=Plasma brain natriuretic peptide level as a biochemical marker of morbidity and mortality in patients with asymptomatic or minimally symptomatic left ventricular dysfunction. Comparison with plasma angiotensin II and endothelin-1">

                                <b>[9]</b>Tsutamoto T, Wada A, Maeda K, et al.Plasma brain natriuretic peptide level as a biochemical marker of morbidity and mortality in patients with asymptomatic or minimally symptomatic left ventricular dysfunction.Comparison with plasma angiotension II and endothelin-1[J].Eur Heart J, 1999, 20 (24) :1799-1807.
                            </a>
                        </p>
                        <p id="23">
                            <a id="bibliography_10" target="_blank" href="http://scholar.cnki.net/result.aspx?q=Plasma brain natriuretic peptide - an independent predictor of cardiovascular mortality in acute heart failure">

                                <b>[10]</b>Yu CM, Sanderson JE.Plasma brain natriuretic peptide:an independent predictor of cardiovascular mortality in acute heart failure[J].Eur J Heart Fail, 1999, 1 (1) :1790-1799.
                            </a>
                        </p>
                        <p id="25">
                            <a id="bibliography_11" target="_blank" href="/kcms/detail/detail.aspx?dbcode=SJWD&amp;filename=SJWD92559FE346A9B42938160DF84827DB7F&amp;v=Mjk4MThURjJmcEdZTzErQlE0OXpSOFE0ajU3U0F1VXBCWTllN1hnTjczcENPTnZGU2lXV3I3SklGcG1hQnVIWWZPR1FsZkJyTFUwNXRCaHhMMjJ3NjQ9TmlmY2FycTZHOQ==&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[11]</b>Kitada S, Kikuchi S, Tsujino T, et al.The prognostic value of brain natriuretic peptide in patients with heart failure and left ventricular ejection fraction higher than 60%:a sub-analysis of the J-MELODIC study[J].ESC Heart Fail, 2018, 5 (1) :36-45.
                            </a>
                        </p>
            </div>
        <!--reference end-->
        <!--footnote start-->
        <!--footnote end-->



    </div>

        <input id="fileid" type="hidden" value="XXGK201904006" />
        <input id="dpi" type="hidden" value="300" />
    </div>

<script>
var _hmt = _hmt || [];
(function() {
  var hm = document.createElement("script");
  hm.src = "https://hm.baidu.com/hm.js?6e967eb120601ea41b9d312166416aa6";
  var s = document.getElementsByTagName("script")[0];
  s.parentNode.insertBefore(hm, s);
})();
</script>

    


<input id="hid_uid" name="hid_uid" type="hidden" value="WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" />
<input id="hid_kLogin_headerUrl" name="hid_kLogin_headerUrl" type="hidden" value="/KLogin/Request/GetKHeader.ashx%3Fcallback%3D%3F" />
<input id="hid_kLogin_footerUrl" name="hid_kLogin_footerUrl" type="hidden" value="/KLogin/Request/GetKFooter.ashx%3Fcallback%3D%3F" />
<div class="btn-link" style="display: none"><a target="_blank" href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=XXGK201904006&amp;v=MDc2ODFUWE1aYkc0SDlqTXE0OUZZb1FLREg4NHZSNFQ2ajU0TzN6cXFCdEdGckNVUjdxZlp1Wm1GeWpnV3J6T1A=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">知网节</a></div>
<div class="popflow" id="popupTips" style="display: none;">
    <div class="popflowArr"></div>
    <div class="popflowCot">
        <div class="hd"><a href="javascript:void(0);" onclick="$('#popupTips').hide();$('#popupmsg').html('')" class="close">X</a></div>
        <div class="bd">
            <p class="mes" id="popupmsg" name="popupmsg"></p>
          
        </div>
    </div>
</div>
<input type="hidden" id="myexport" value="//kns.cnki.net" />

<input type="hidden" id="KPCAPIPATH" value="//ishufang.cnki.net" />
<input type="hidden" id="CitedTimes" value="" />
<div class="link" id="GLSearch" style="display: none;">
    <i class="icon-trangle"></i>
    <div class="inner">
        <a class="icon" id="copytext">复制</a>
        <a class="icon" target="_blank" onclick="searchCRFD(this)">工具书搜索</a>
    </div>
</div>




<input id="hidVirtualPath" name="hidVirtualPath" type="hidden" value="/kxreader" />
<script src="/kxreader/bundles/detail?v=842_VlRz_g1CMCLi-M0twVw-4EOFG_noWyi_OsMnrAg1"></script>

<script src="/kxreader/Scripts/layer.min.js" type="text/javascript"></script>

<div id="footerBox" class="rootw footer">
</div>
<script>
    if (typeof FlushLogin == 'function') {
        FlushLogin();
    }
    modifyEcpHeader(true);
</script>

<!--图片放大功能 start-->
<script src="/kxreader/bundles/imagebox?v=W4phPu9SNkGcuPeJclikuVE3PpRyIW_gnfjm_19nynI1"></script>

<script type="text/javascript">
    $(function () {
        var j = $.noConflict();
        j(function () {
            j(".zoom-in,.btn-zoomin").imgbox({
                'alignment': 'center',
                'allowMultiple': false,
                'overlayShow': true
            });
        })
    });
</script>
<!--图片放大功能 end-->
<div class="fixedbar">
    <div class="backtop hiddenV" id="backtop">
        <a id="backTopSide" href="javascript:scroll(0,0);" title=""></a>
    </div>
</div>
<script type="text/javascript" src="/kxreader/Scripts/MathJax-2.6-latest/MathJax.js?config=MML_HTMLorMML-full"></script>

</body>
</html>
